Também conhecido como
[Often referred to by brand name (see MedlinePlus Drug Information)]
Nome formal
Este artigo foi revisto pela última vez em
Este artigo foi modificado pela última vez em 10 de Julho de 2017.
At a Glance
Why Get Tested?
To determine the concentration of cyclosporine in your blood in order to establish a dosing regimen, maintain therapeutic levels, and detect toxic levels
When To Get Tested?
As soon as cyclosporine therapy begins, usually daily or 2-3 times a week, and periodically after that as dose is adjusted or maintained
Sample Required?
A blood sample drawn from a vein in your arm
Test Preparation Needed?
What is being tested?
This test measures the amount of cyclosporine in the blood. Cyclosporine is an immunosuppressive drug used to dampen the body’s natural defenses. When patients undergo an organ transplant, their immune system recognizes the graft as a foreign substance and will begin to attack it just as it would any invasive bacteria or virus. Cyclosporine affects the ability of certain white blood cells in the immune system to respond to this foreign tissue. The transplanted organ then has a better chance of survival and will not be as easily rejected by the patient’s system. Cyclosporine is used routinely in the transplantation of kidney, heart, liver, and other organs.

The immunosuppressive qualities of cyclosporine have also been found to be useful in treating symptoms of some autoimmune and other disorders. These conditions are characterized by the immune system reacting to the body’s own cells or tissue. Cyclosporine helps to control the immune response in these cases, decreasing the severity of symptoms. Some examples include rheumatoid arthritis, psoriasis, aplastic anemia, and Crohn’s disease.

When the symptoms in these cases are judged to be severe, extensive, and disabling, cyclosporine may be prescribed. Usually, the symptoms have not responded well to other treatments or medications. Cyclosporine is used with caution in these cases and needs to be carefully monitored with blood tests.

Testing cyclosporine levels in the blood can help ensure that drug levels are in a range that will be therapeutic for you. If the level is too low, organ rejection may occur (in the case of transplantation) or symptoms may reappear (autoimmune cases). It is also important to ensure levels are not too high and will not result in toxicity.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

Is any test preparation needed to ensure the quality of the sample?

No test preparation is needed.
Accordion Title
Common Questions
  • How is it used?
    The test for cyclosporine is ordered to measure the amount of drug in the blood to determine whether drug concentrations have reached therapeutic levels and are not in a toxic range. It is important to monitor levels of cyclosporine for several reasons:

  • There is not a good correlation, as with some other medications, between the dose of cyclosporine given and level of drug in the blood.
  • Absorption and metabolism of oral doses of cyclosporine can vary greatly between patients and even in the same patient depending on the time of dose and what food is eaten.
  • There can be variation in blood levels due to the brand or preparation of cyclosporine prescribed.
  • In transplant patients, it is particularly important for graft survival to ensure that cyclosporine levels are high enough immediately following surgery to prevent rejection of the transplanted organ.
  • Blood levels need to be high enough in the case of rheumatoid arthritis or psoriasis to begin to give relief of symptoms.
  • In the case of kidney transplantation, blood levels may help to distinguish between kidney rejection and kidney damage due to high levels of cyclosporine.
  • Cyclosporine is associated with several toxic side effects that can be avoided if blood levels are monitored and the dose adjusted if the level detected is too high.
  • By monitoring cyclosporine blood levels, doctors can better ensure that each individual is receiving the right amount and formulation of drug needed to treat their particular case.

  • When is it ordered?
    Cyclosporine is ordered frequently at the start of therapy, often on a daily basis when trying to establish a dosing regimen. Once an appropriate dose has been determined, the level can be tested less frequently and may eventually be tested once every 1-2 months.

    Often in transplantation, patients will begin with higher doses of cyclosporine at the start of therapy and then decrease the dose over the course of long-term therapy. In the cases of rheumatoid arthritis or psoriasis, if a patient appears to tolerate the drug well, the dose may be increased to further improve symptoms. With each change in dose, blood levels need to be measured. In addition, the frequency of testing depends on a number of factors including type of organ transplanted, age, and general health status of the patient. For example, a patient with a transplanted liver may need to be monitored more regularly since cyclosporine is metabolized mainly by the liver, and impaired function can slow clearance of cyclosporine from the blood. Tests may also be ordered more often when organ rejection or kidney toxicity is suspected.

  • What does the test result mean?
    The therapeutic range for cyclosporine depends on both the method used to measure the drug and the type of transplant. Results obtained from different types of samples and different methods are not interchangeable. Your doctor will be guided by the laboratory that does the testing as to the appropriate therapeutic range to apply to your test result.

    A majority of institutions use whole blood samples instead of serum or plasma and will collect samples 12 hours after the last dose or just before the next dose (trough levels). Some laboratory methods are more specific for the cyclosporine parent drug while others measure the parent drug plus the metabolites so their respective ranges will differ.

    If trough levels fall below the desired range, there is a risk of transplant rejection or symptom recurrence. If levels detected are above the range, there is a risk of toxic side effects.

    Some signs or symptoms of cyclosporine toxicity are:

  • kidney damage
  • high blood pressure
  • tremors
  • bleeding, swelling, overgrowth of gums li>
  • hirsutism
  • hyperlipidemia
  • Peak concentrations of samples collected 2 hours post dose are sometimes tested in transplant cases. High levels of cyclosporine in peak samples are correlated with reduced rejection rates, especially in the first year after transplant surgery.

  • Is there anything else I should know?
    Because cyclosporine therapeutic ranges can vary with type of assay performed by the laboratory, it is advised that your blood samples be tested by the same institution over the course of therapy. Results will be more consistent and will correlate better with the reported therapeutic range.

    For conditions other than transplants, cyclosporine may be prescribed with other medications such as non-steroidal anti-inflammatory drugs (NSAIDs). In transplant cases, other anti-rejection drugs may be used along with cyclosporine. These drugs will work in conjunction to treat your condition. In addition, cyclosporine blood levels can be affected by other medications you may be taking. You should notify the doctor who is monitoring your cyclosporine levels of any additional drugs you are taking.

    Cyclosporine can cause damage to the kidneys, especially with higher blood levels and over a longer period of time. Your doctor may want to monitor kidney function tests. Increases in blood lipid levels have been noted in some cases and liver function may be affected in cyclosporine therapy as well. Your doctor may order additional laboratory tests to detect high lipid levels or to see if your liver has been affected.

  • How long will I need to be on cyclosporine?
    Transplant patients generally will stay on cyclosporine as long as that is the treatment of choice for them. If there are signs of rejection, even with blood levels in the therapeutic range, they may be switched to a different immunosuppressive drug. Also, there is a greater chance of toxic side effects the longer a patient is on cyclosporine, so a doctor may choose to alter drug therapy when a transplant patient has been on cyclosporine for more than 2-3 years.

    Patients with an autoimmune disorder such as rheumatoid arthritis, Crohn’s disease, or psoriasis will be treated with cyclosporine only when their symptoms are acute and if other treatments have not been effective. It is not advised that these patients be on cyclosporine for more than a year due to the increase in the likelihood of toxic symptoms the longer they are on the medication. Short-term or intermittent courses of 12 weeks at a time are more advisable.

  • Who orders cyclosporine tests?
    Cyclosporine will usually be monitored by doctors who have specific knowledge of the condition or disease for which the drug is prescribed. They tend to be very familiar with cyclosporine and its use in therapy, and they understand the importance of monitoring the drug. They may include your surgeon or your doctor treating you for your arthritis or psoriasis.
  • Can I test my cyclosporine level at home?
    No, cyclosporine testing involves special handling and complex procedures and instruments for accurate results.
  • View Sources
    A Manual of Laboratory & Diagnostic Tests. 6th ed. Fischbach F, ed. Philadelphia: Lippincott Williams & Wilkins; 2000.

    Clinical Chemistry: Principles, Procedures, and Correlations. Bishop M, Duben-Engelkirk J, Fody E, eds. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.

    Clinical Diagnosis and Management by Laboratory Methods. 20th ed. Henry JB, ed. New York: Saunders: 2001.

    Sacher RA, McPherson RA, Campos J. Widmann’s Clinical Interpretation of Laboratory Tests. 11th ed. Philadelphia: F.A. Davis Company; 2000.

    Karen L. Hardinger, Pharm.D. Matthew J. Koch, M.D.; Daniel C. Brennan, M.D., FACP (Posted 10/01/2004) Current and Future Immunosuppressive Strategies in Renal Transplantation, Medscape from Pharmacotherapy. Available online: http://www.medscape.com/viewarticle/489357

    TOXNET, Toxicology Data Network, (April 2006) Hazardous Substance Database, Division of Specialized Information Services (SIS) of the National Library of Medicine (NLM). (Online information-Search cyclosporine). Available online: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB

    Medscape detailed monograph, Oral Cyclosporine (April 2006) Online information

    Michael R. Lucey; Manal F. Abdelmalek; Rosemarie Gagliardi; Darla Granger; Curtis Holt; Igal Kam; Goran Klintmalm; Alan Langnas; Kirti Shetty; Andreas Tzakis; E. Steve Woodle (2005) A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status, Medscape from American Journal of Transplantation, 5(5):1111-1119. Available online: http://www.medscape.com/viewarticle/503095

    Well, G (2005) Cyclosporine for treating rheumatoid arthritis. Cochrane Rev Abstract, The Cochrane Collaboration. Available online: http://www.medscape.com/viewarticle/485484

    Naldi, L., Griffiths, CEM (2005). Traditional Therapies in the Management of Moderate to Severe Chronic Plaque Psoriasis: An Assessment of the Benefits and Risks. British Journal of Dermatology 152(4): 597-615. Available online: http://www.medscape.com/viewarticle/503441